# Clinical Impact of Rare and Compound Mutations of Epidermal Growth Factor Receptor in Patients With Non–Small-Cell Lung Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/clinical-impact-of-rare-and-compound-mutations-of-epidermal-growth-factor/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Juliane Martin,Annika Lehmann,Frederick Klauschen,Michael Hummel,Dido Lenze,Christian Grohé,Antje Tessmer,Joachim Gottschalk,B. Peter Schmidt,H. W. Pau,Christian Witt,Stefan Moegling,Robert Kromminga,Korinna Jöhrens |
| Citations | 18 |
| DOI | 10.1016/j.cllc.2019.04.012 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2944206462 |
| PMID | 31175009 |
| Type | article |
| Year | 2019 |

## Paper authors

- [H. W. Pau](https://scholariq.org/researchers/h-w-pau/)

## Paper journal

- [Clinical Lung Cancer](https://scholariq.org/journals/clinical-lung-cancer/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.